Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review

Vicki Freedenberg1, Sue A Thomas, Erika Friedmann

  • 1Department of Cardiology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA.

Heart Failure Clinics
|November 27, 2010
PubMed

Insights

Implanted cardioverter-defibrillators (ICDs) can cause anxiety and depression in patients, particularly younger females who receive shocks. Early screening and interventions like cognitive behavioral therapy are recommended for ICD recipients with heart failure.

Area of Science:

  • Cardiology
  • Psychology
  • Medical Devices

Background:

  • Implanted cardioverter-defibrillators (ICDs) reduce mortality but can negatively impact psychological well-being.
  • A significant portion of ICD recipients experience anxiety and depression post-implantation, persisting for up to a year.
  • Heart failure (HF) patients with ICDs are also susceptible to psychological distress.

Purpose of the Study:

  • To assess the psychological impact of ICD implantation on patients.
  • To identify patient subgroups vulnerable to psychological distress.
  • To evaluate the effectiveness of interventions for psychological distress in ICD recipients with HF.

Main Methods:

  • Review of existing literature on ICDs and patient psychological status.
  • Analysis of factors contributing to anxiety and depression in ICD recipients.
  • Examination of therapeutic interventions for psychological distress.

Main Results:

  • ICD implantation is associated with increased rates of depression and anxiety.
  • Younger patients, females, and those experiencing ICD shocks are at higher risk.
  • Cognitive behavioral therapy and psychoeducational programs show potential in mitigating distress for HF patients.

Conclusions:

  • Psychological screening for anxiety and depression is crucial for all ICD recipients.
  • Targeted interventions are needed for vulnerable populations, especially those with heart failure.
  • Further research into optimizing psychological support for ICD patients is warranted.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...